Atlas Trials

Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes

Clinical trial NCT00734253 · COMPLETED

Trial details

NCT number
NCT00734253
Sponsor
NephroGenex, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Nephropathy
Start date
2008-08-01
Primary completion
2010-08-01
Enrollment
317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.